Romain Riscal

1.6k citations
12 papers · 822 indexed · h-index 9
Topics
Cancer, Hypoxia, and Metabolism (7 papers)Cancer-related Molecular Pathways (6 papers)Epigenetics and DNA Methylation (5 papers)
Journals
SHILAP Revista de lepidopterologíaMolecular CellNature Cell Biology
Partner nations
United StatesFranceChina

In The Last Decade

Romain Riscal

12 papers receiving 814 citations

Peers

Romain Riscal
Comparison fields: 5 of 78
  • Molecular Biology 492
  • Cancer Research 356
  • Oncology 192
  • Pulmonary and Respiratory Medicine 118
  • Surgery 103
Replace Danyu Du with:
Danyu Du China
Russell Ericksen United States
Alexander R. Terry United States
Yung-Sheng Chang Taiwan
Yifeng Tian China
Yoshiaki Sunami Germany
Yeonhwa Song South Korea
Mitsuhiko Abe Japan
Yun‐Xin Lu China
Shamir Cassim France
Romain Riscal relative to Danyu Du China Danyu Du's profile →
Citations per field
00.5×3.6×
Danyu Du · 1×
Citations per year

Countries citing papers authored by Romain Riscal

Since Specialization
Citations

This map shows the geographic impact of Romain Riscal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romain Riscal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romain Riscal more than expected).

Fields of papers citing papers by Romain Riscal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romain Riscal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romain Riscal. The network helps show where Romain Riscal may publish in the future.

Co-authorship network of co-authors of Romain Riscal

This figure shows the co-authorship network connecting the top 25 collaborators of Romain Riscal. A scholar is included among the top collaborators of Romain Riscal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romain Riscal. Romain Riscal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 9
2 1
3 3
4 102
5 29
6 151
7 35
8 239
9 144
10 16
11 91
12 2

About Romain Riscal

Romain Riscal is a scholar working on Cancer Research, Oncology and Biochemistry, having authored 12 papers that have together received 822 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Cancer-related Molecular Pathways (6 papers) and Epigenetics and DNA Methylation (5 papers). The work is most often cited by research in Cancer Research (356 citations), Molecular Biology (492 citations) and Oncology (192 citations). Romain Riscal has collaborated with scholars based in United States, France and China. Frequent co-authors include M. Celeste Simon, Nicolas Skuli, Laurent Le Cam, Laëtitia K. Linares, Giuseppe Arena, Matthieu Lacroix, Michelle Burrows, Fuming Li, Kathy Guo and Ian A. Blair. Their work appears in journals such as SHILAP Revista de lepidopterología, Molecular Cell and Nature Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026